Pennington Biomedical launches weight loss study for young adults

LSU’s Pennington Biomedical Research Center has launched a clinical trial to evaluate weight regulation in adults taking GLP-1 medications.

FTMQ Health, written by our newsroom19 October 2026 at 01:030 views

Louisiana State University’s Pennington Biomedical Research Center is conducting a clinical trial to evaluate how GLP-1 medications regulate body weight, according to The Reveille. The study aims to make these medical treatments more effective for weight loss. [1]

The Reveille reported that the trial, named DIP or Dual Intervention point, focuses on monitoring body weight regulation. The researchers are recruiting human participants between the ages of 18 and 40. [1]

According to The Reveille, study volunteers can receive up to $1,500 in compensation. In addition, individuals who are not selected for the trial can request copies of their lab work and body composition scan results, dietitian and participant coordinator Kelsey Maguire noted. [1]

Research into targeted health interventions can improve efficiency and care accessibility, as FTMQ Health reported earlier regarding screening programs. [2]

LSU’s Pennington Biomedical Research Center is conducting the DIP clinical trial.
The study recruits human participants aged 18 to 40 to evaluate GLP-1 medication effectiveness.
Participants can receive compensation of up to $1,500.

Sources

Every paragraph above points to the numbered items it rests on. Read the originals here.

[1]Pennington Biomedical research study makes medical screening more accessible for studentsThe Reveille, LSU's student newspaper, 3h ago (the report this story comes from)

Background

[2]Targeted screening in Malawi could improve tuberculosis detection and lower costs FTMQ Health, 11d ago

Our newsroom writes these reports with the help of software, from the 2 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.

Get the day in one email

Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.

By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments

Join the conversation

Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.

Already on the list? Enter the same address and we will send a sign-in link.